ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-45661

Dokploy is a free, self-hostable Platform as a Service (PaaS).

Published May 29, 2026 · catalog updated Oct 6, 2026 · Dokploy is a free,

Check if you run it

No confirmed exploitation is on record for CVE-2026-45661. EPSS is 0.81%. Act only if a listed version of Dokploy is a free, is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Dokploy is a free,).
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.9
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.81%
Remediation
Version ranges on file
Affected products
stated named in the record

Dokploy is a free, self-hostable Platform as a Service (PaaS). In 0.26.5 and earlier, a critical path traversal vulnerability exists in Dokploy v0.26.5 that allows authenticated users to write arbitrary files to the filesystem during application deployment. When combined with Dokploy's remote server deployment feature, this vulnerability enables arbitrary file write to remote server filesystems, automatic remote code execution via cron jobs, complete server compromise, data exfiltration without user interaction, and persistent backdoor installation. This vulnerability bypasses all container isolation on remote server deployments.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • stated named in the record<= 0.26.5

How to fix CVE-2026-45661

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-45661. EPSS is 0.81%. Act only if a listed version of Dokploy is a free, is installed.

Which versions are affected?

Compare what you have installed with named in the record <= 0.26.5. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-22: Path Traversal; CWE-35. EPSS 0.81%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. May 29, 2026 · NIST NVD

    Detected

    Dokploy is a free, self-hostable Platform as a Service (PaaS). In 0.26.5 and earlier, a critical path traversal vulnerability exists in Dokploy v0.26.5 that allows authenticated users to write arbitrary files to the filesystem during application deployment. When combined with Dokploy's remote server deployment feature, this vulnerability enables arbitrary file write to remote server filesystems, a

  2. Oct 6, 2026 · NIST NVD

    Updated

    Dokploy is a free, self-hostable Platform as a Service (PaaS). In 0.26.5 and earlier, a critical path traversal vulnerability exists in Dokploy v0.26.5 that allows authenticated users to write arbitrary files to the filesystem during application deployment. When combined with Dokploy's remote server deployment feature, this vulnerability enables arbitrary file write to remote server filesystems, a

Sources

  • CVE.orgVulnerability recordCVE-2026-45661

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-45661

    30-day exploitation probability 0.8%

    first.org
  • NIST NVDVulnerability recordCVE-2026-45661

    Dokploy is a free, self-hostable Platform as a Service (PaaS). In 0.26.5 and earlier, a critical path traversal vulnerability exists in Dokploy v0.26.5 that allows authenticated users to write arbitrary files to the filesystem during application deployment. When combined with Dok

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.